Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001662002-16-000002
Filing Date
2016-12-05
Accepted
2016-12-05 13:22:08
Documents
1
Effectiveness Date
2016-12-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8311
  Complete submission text file 0001662002-16-000002.txt   9381
Mailing Address 1616 EASTLAKE AVENUE EAST SUITE 202 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVENUE EAST SUITE 202 SEATTLE WA 98102 61430589444
Nohla Therapeutics Inc. (Filer) CIK: 0001662002 (see all company filings)

EIN.: 475261773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-275626 | Film No.: 162033295